| ORAL PRESENTATION |
|
| Year : 2012 | Volume
: 32
| Issue : 5 | Page : 14 |
|
|
OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study
Madhuri Hemant Wagh
Dravyaguna, Govt. Ayurveda College, Nagpur, Maharashtra, India
Correspondence Address:
Madhuri Hemant Wagh
Dravyaguna, Govt. Ayurveda College, Nagpur, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Purpose : Obesity, the state of excessive adipose tissue, with increased morbidity, mortality from numerous diseases nearly in a pandemic stage; necessitates urgent search for safe, effective anti-obesity medications, as extant modern drugs have significant major adverse effects. Charaka elaborated very lucidly qualitative signs & symptoms of obesity (Sutrasthan A21). Gorakhmundi (Sphaeranthus indicus), a widely available seasonal wild herb, called Som-Sum-Veerya (Sushruta), Palankash (weathers fat away; Shaligram), Mundi (beheads diseases), anti-obesity effects mentioned in seven Nighantu(s); thus holds promise. This study evaluates its anti-obesity efficacy using single-blind, placebo-controlled design.
Method: Forty persons (age 25-50 yrs), 20 each in study and control groups, with weight >10kg excess than LIC actuarial mean normal, evaluated at baseline using BMI, Waist/Hip Ratio, skin-fold thickness at Biceps, Triceps, Sub-scapular & Supra-iliac sites and also 23 qualitative criteria collated from Ayurveda's Classical Texts; were administered for 90 days at 2gm/day dose either Gorakhmundi Panchang-Choorna or Spinach Choorna respectively and reassessed monthly. Anthropometric measurements analysed using descriptive statistics & paired t test. Qualitative criteria- descriptive statistics.
Result : At 90 days, Study Group shows -->5% weight reduction in 45%, 3-5% in 45%, 0.334/week or 1.34/month, Highly Significant- weight reduction, p<0.001, - Improvement in- BMI, p<0.001; W/H Ratio, p<0.001; -- Skin-fold Triceps, Subscapular, Suprailiac, p<0.001, (Biceps p<0.05), Qualitative features viz. Body Mal-odor, Hyper-sweating, heaviness, slackness, lack of swiftness, laziness, exercise intolerance, deep breathing discomfort, excessive thirst showed considerable improvement in majority persons showing these at baseline.
Conclusion: Study confirms Gorakhmundi's significant anti-obesity efficacy, using single-blind placebo-control design and modest sample. |
|
|
|
| [PDF]* |
|
 |
|
